Sales of Trulicity were in line with the Zacks Consensus Estimate ... markets and improved supply from ramped-up production. Lilly and Novo Nordisk are presently dominating the obesity market ...

Novo Nordisk is gradually ending production of human insulin ... Boxes of Wegovy move along a packaging line at Novo Nordisk’s facility in Hillerod, Denmark. File image/ Reuters But the delivery ...

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover ...

U.S.-listed shares of Novo Nordisk declined in the opening minutes of trading Friday on the surprise news that CEO Lars ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Novo reported $11.9 billion in revenue, in line ... Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. (Kristian Tuxen Ladegaard Berg/SOPA Images ...

Novo Nordisk will invest around $1 billion to expand its production site in Montes Claros, Brazil, marking one of the largest pharmaceutical investments in the nation’s history. The company’s ...

Novo Nordisk beat earnings estimates but slightly missed top-line revenue expectations. However, the results throughout its business were quite strong, and management gave an upbeat outlook for ...

Bank of America analysts point out that currency hedging will help cushion the blow on Novo Nordisk's bottom line. They also pointed ... in a very simple device solution is very convenient for ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

Novo Nordisk stock (NVO) jumped more than 2% in ... Novo reported $11.9 billion in revenue, in line with Wall Street's estimates, and beat on adjusted earnings per share (EPS) with $0.99 per ...

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 billion DKK ($11.9 billion). Net income for the quarter rose 14% to 29 ...